Mixed Antagonist of Serotonin for Claudication Optimal Therapy

Completed · Phase 2

Conditions studied: Intermittent Claudication

In brief

To investigate in patients suffering from intermittent claudication due to Fontaine stage II PAD whether a 24-week treatment by SL650472 OD on top of clopidogrel may result in an improvement of walking capacity, by comparing three doses of SL650472 to placebo, and to calibrate such effect versus cilostazol

Key facts

Study ID: NCT00300339
Run by: Sanofi
People needed: 599
Starts: 2006-02-01
Expected to finish: 2007-12-01
Last updated by the study team: 2008-12-19

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

1. Patient with stable symptoms of intermittent claudication of the lower extremities, secondary to chronic occlusive arterial disease from atherosclerosis origin (symptoms present for 6 months or longer and not significantly changed within the past 3 months);
2. ICD of 30 to 200 m at screening constant workload treadmill test
3. Doppler-measured pre-treadmill ABI of 0.90 or lower after 10 minutes of rest or, for patients with an ABI of greater than 1.3 (non-compressible arteries), a Toe-Brachial Index (TBI) of less than 0.7.

You may not qualify if…

1. Age below 40 years and/or onset of symptoms of PAD before the age of 40 years;
2. Non-atherosclerotic vascular disease (e.g. Buerger's disease, popliteal entrapment syndrome);
3. Limb-threatening (grades III and IV) chronic limb ischemia, manifested by ischemic rest pain, ulceration, or gangrene.
4. Patients with a history of malignant or proliferate breast disease.

Where it is running

Sanofi-Aventis Administrative Office — Bridgewater, New Jersey, United States
Sanofi-Aventis Administrative Office — Diegem, Belgium
Sanofi-Aventis Administrative Office — Laval, Canada
Sanofi-Aventis Administrative Office — Prague, Czechia
Sanofi-Aventis Administrative Office — Berlin, Germany
Sanofi-Aventis Administrative Office — México, Mexico
Sanofi-Aventis Administrative Office — Moscow, Russia
Sanofi-Aventis Administrative Office — Bromma, Sweden
Sanofi-Aventis Administrative Office — Kiev, Ukraine

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.